Remove Leads Remove Pharmaceutical Remove Pharmaceutical research Remove Training
article thumbnail

Johnson & Johnson appoints new Executive Vice President, Pharmaceuticals, R&D

European Pharmaceutical Review

Johnson & Johnson ( J&J ) has announced that Dr John Reed, PhD, will become the company’s Executive Vice President of Pharmaceuticals, R&D on April 3, 2023. to the Company’s Executive Committee as Executive Vice President of Pharmaceuticals, R&D. Johnson & Johnson today announced the appointment of John Reed, M.D.,

article thumbnail

Why is microbiological testing in medical device manufacturing important?

European Pharmaceutical Review

A paper published in the Journal of Pharmaceutical Research International has reviewed microbiological testing for medical devices and described their applications and challenges. This can require specialised expertise and training, according to the paper. appeared first on European Pharmaceutical Review. Sharma et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

Are your interest piqued by the words ‘pharmaceutical sales’? Let’s look at the exciting possibilities, essential skills, and valuable resources that can prepare you for success with the entry-level pharmaceutical sales. Internships: While less common than seeking full-time jobs, this could still be a possible intent.

Sales 52
article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. Primarily because of a fact that the pharmaceutical industry has known for some time—constant, honest, and meaningful communication with prescribers is lacking in the post-pandemic world. August 23, 2022. Why you may ask?

Pharma 52
article thumbnail

The Future for Biotesting

Pharmaceutical Technology

Now the company is a GLP-certified contract research organisation that focuses on three main domains. Firstly, there is a comprehensive toxicological service for human and veterinary pharmaceuticals and biopharmaceuticals, food additives, chemicals and agrochemicals. It will most probably lead to a new anti-flu vaccine.